BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act.
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO

Business

Triangle biotech businesses big winners under new medical research law

December 20, 2016 5:26 PM

  Comments  

Videos